BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1066 related articles for article (PubMed ID: 26880610)

  • 21. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
    Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW;
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
    Roncati L
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.
    Graham RP; Kerr SE; Butz ML; Thibodeau SN; Halling KC; Smyrk TC; Dina MA; Waugh VM; Rumilla KM
    Am J Surg Pathol; 2015 Oct; 39(10):1370-6. PubMed ID: 26099011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.
    Copija A; Waniczek D; Witkoś A; Walkiewicz K; Nowakowska-Zajdel E
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28067827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
    J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma.
    Bao F; Panarelli NC; Rennert H; Sherr DL; Yantiss RK
    Am J Surg Pathol; 2010 Dec; 34(12):1798-804. PubMed ID: 21107085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
    Gologan A; Sepulveda AR
    Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine.
    Yamamoto H; Imai K
    Semin Oncol; 2019 Jun; 46(3):261-270. PubMed ID: 31537299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.
    Czink E; Kloor M; Goeppert B; Fröhling S; Uhrig S; Weber TF; Meinel J; Sutter C; Weiss KH; Schirmacher P; Doeberitz MVK; Jäger D; Springfeld C
    Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28619747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum.
    Planck M; Rambech E; Möslein G; Müller W; Olsson H; Nilbert M
    Cancer; 2002 May; 94(9):2502-10. PubMed ID: 12015776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability in colorectal cancer.
    Iacopetta B; Grieu F; Amanuel B
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):260-9. PubMed ID: 21114775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
    Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
    J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can the histological type of colorectal cancer determine the carcinogenesis pathway?
    Kołos M; Wasążnik-Jędras A; Nasierowska-Guttmejer A
    Pol J Pathol; 2015 Jun; 66(2):109-20. PubMed ID: 26247523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
    Danaher P; Warren S; Ong S; Elliott N; Cesano A; Ferree S
    J Immunother Cancer; 2019 Jan; 7(1):15. PubMed ID: 30665466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
    Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
    Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.